Clinical Trial Update: Cannabis for Inflammatory Bowel Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes Phase 1/Phase 2 studies evaluating cannabis for inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: Meir Medical Center | Conditions: Crohn's Disease, Ulcerative Colitis | Phase 1, Phase 2 | Status: UNKNOWN